For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Covid-19: 5230 new cases, 20 further deaths
FREE READ
+News
FREE READ
Covid-19: 5230 new cases, 20 further deaths
Tuesday 11 June 2024, 03:16 PM

[Image: Fusion Medical Animation on Unsplash]
There have been 5230 new cases of Covid-19 reported in New Zealand over the week to Sunday, and 20 further deaths attributed to the virus.
Of the new cases, 360 were probable cases and 3429 were reinfections.
There were 354 cases in hospital and none in intensive care, as of midnight on Sunday.
Last week, the ministry reported 6142 new cases of Covid-19 and one further death.
It comes just weeks after Covid cases spiked to their highest level in 18 months, and warnings of a "significant" wave of the virus likely to hit New Zealand this winter.
The seven-day rolling average of new cases was 676.
For more news from around New Zealand, go to RNZ.